Hiroya Ojiri

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma

Hideaki Takahashi, Yuichiro Tada, Takashi Saotome et al. · Journal of Clinical Oncology · 2018 · 256 citations

Medicine, Oncology, Pharmacology +15

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma

C. Fushimi, Yuichiro Tada, Hideaki Takahashi et al. · Annals of Oncology · 2017 · 220 citations · Full text

Medicine, Oncology, Pharmacology +13

Potentially Distinctive Features of Sinonasal Inverted Papilloma on MR Imaging

Hiroya Ojiri, Masuo Ujita, Shimpei Tada et al. · American Journal of Roentgenology · 2000 · 148 citations

Medicine, Oncology, Radiology +16

Evaluation of Cartilage Invasion by Laryngeal and Hypopharyngeal Squamous Cell Carcinoma with Dual-Energy CT

Hirofumi Kuno, Hiroaki Onaya, Ryoko Iwata et al. · Radiology · 2012 · 111 citations

Medicine, Oncology, Radiology +16

Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma

Hiroya Ojiri, William M. Mendenhall, Scott P. Stringer et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 93 citations

Medicine, Oncology, Radiation Oncology +17